Isoliquiritigenin limits inflammasome activation of macrophage via docking into Syk to alleviate murine non-alcoholic fatty liver disease
PMID: 38671579
Source: Scand J Immunol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL